Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» February 2012
February 2012
Medivation says prostate cancer pill MDV3100 met goal in second clinical trial
Medivation says prostate cancer pill MDV3100 met goal in second clinical trial
Yahoo/AP
Medivation
prostate cancer
MDV3100
Alnylam Gets New Patent
Alnylam Gets New Patent
Yahoo/Zacks
Alnylam
patents
MC3 lipid
Easing The Pain: Why Investment In Bio-Pharma Is A Worthy Cause
Easing The Pain: Why Investment In Bio-Pharma Is A Worthy Cause
Seeking Alpha
Bristol-Myers Squibb
Ariad Pharmaceuticals
Inhibitex
Vertex Pharmaceuticals
Spectrum Pharmaceuticals
MannKind
Docs Are Surrendering To Generics: Survey
Docs Are Surrendering To Generics: Survey
Pharmalot
physicians
generics
Allergan Pulls Doctor Payment Data From Web Site
Allergan Pulls Doctor Payment Data From Web Site
Pharmalot
Allergan
physician payments
Dendreon And Provenge's True Median Life-Extension Benefit
Dendreon And Provenge's True Median Life-Extension Benefit
Seeking Alpha
prostate cancer
Provenge
Dendreon
Checking the Quality of Teva's Growth
Checking the Quality of Teva's Growth
Motley Fool
Teva Pharmaceuticals
Are ISTA Pharmaceuticals' Numbers Better Than They Look?
Are ISTA Pharmaceuticals' Numbers Better Than They Look?
Motley Fool
Ista
Auxilium recieves cautious assessment for Xiaflex, says Leerink
Auxilium recieves cautious assessment for Xiaflex, says Leerink
Yahoo/Fly on the Wall
Auxilium
Xiaflex
Pfizer
Dupuytren's Contracture
breast cancer
Eisai
Halaven
Impax Labs licenses Astrazeneca's migraine drug in US
Impax Labs licenses Astrazeneca's migraine drug in US
Reuters
AstraZeneca
Impax Labs
migraines
Zomig
Pages
« first
‹ previous
…
35
36
37
38
39
40
41
42
43
next ›
last »